DEBRA BRADSHAW: Open Payments
NPI 1902354319 · ORLAND PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,117 in 46 payments from 14 companies in 2025. Trend: 2023 $1,121 · 2024 $1,148 · 2025 $1,117
Food & beverage: $1,117
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $198 |
| Janssen Pharmaceuticals, Inc | 8 | $191 |
| ABBVIE INC. | 7 | $168 |
| Neurocrine BioSciences, Inc. | 4 | $104 |
| Axsome Therapeutics, Inc. | 4 | $99 |
| Alpha Cognition USA, Inc. | 2 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $59 |
| E.R. Squibb & Sons, L.L.C. | 2 | $47 |
| Alkermes, Inc. | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
Products named: VRAYLAR, SPRAVATO, ABILIFY ASIMTUFII, INGREZZA, Zunveyl, Auvelity, REXULTI, TRINTELLIX.
Industry payments across IL — which companies pay providers there.
